Yida Tang, M.D., Ph.D., FSCAI

Fuwai Hospital, National Center for Cardiovascular Diseases
Beijing People's Republic of China

Papers:

Clopidogrel Response Evaluation and Anti-platelet Intervention in High Thrombotic Risk PCI Patients (CREATIVE trial): Results of 3-Year Follow-up
CYP2C19 Genotype has a Greater Prognostic Value in Specific Population Following Coronary Stenting